Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hemangioma × Ointments × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 4 Vascular Malformations 1 Uterine Cervical Dysplasia 1 Surgical Wound Infection 1 Pilonidal Sinus 1 Pancreatic Neoplasms 1 Pain 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 High-grade Anal Intraepithelial Neoplasia 1 Hemangioma, Capillary 1 Hemangioma 1 Head and Neck Neoplasms 1 Dermatitis, Contact 1 Condylomata Acuminata 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Cancer Lymphedema 1

Interventions

Propranolol 8 Timolol 5 Prednisone 3 Prednisolone 3 Adrenergic beta-Antagonists 3 Solutions 2 Saline Solution 2 Adrenal Cortex Hormones 2 prednisolone phosphate 1 Vincristine 1 Tomography, Optical Coherence 1 Steroids 1 Sodium Chloride 1 Sirolimus 1 Population Groups 1 Ointments 1 Nadolol 1 Mupirocin 1 Methylprednisolone 1 Leuprolide 1 Lasers, Semiconductor 1 Lasers, Dye 1 Imiquimod 1 Gels 1 Everolimus 1 Bleomycin 1 Atenolol 1 Acebutolol 1 68Ga-1,4,7-triazacyclononane-N,N',N''-triacetic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01408056 2014-01-17

TOUCH

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Hemangioma, Hemangioma, Capillary, Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon ⚡